• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by OneMedNet Corp

    10/1/24 5:01:18 PM ET
    $ONMD
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care
    Get the next $ONMD alert in real time by email
    SC 13G 1 otc241037_sc13g.htm SC 13G

     

      UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

      SCHEDULE 13G

     

    Under the Securities Exchange Act of 1934

    (Amendment No.__)*

     

    OneMedNet Corporation

     

    (Name of Issuer) 

     

    Common Stock, par value $0.0001 per share

     

      (Title of Class of Securities)  

     

    68270C103

     

    (CUSIP Number)

     

    September 25, 2024

     

      (Date of Event which Requires Filing of this Statement)  

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

    ☐Rule 13d-1(b)

    ☒Rule 13d-1(c)

    ☐Rule 13d-1(d)

     

    *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

     

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     

     

    SCHEDULE 13G 

    CUSIP No. 68270C103    

     

    1

    NAME OF REPORTING PERSON 

    Off the Chain LP

     

    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (See Instructions)

    (a) ☐

    (b) ☒ 

    3

    SEC USE ONLY

     

    4

    CITIZENSHIP OR PLACE OF ORGANIZATION 

    Delaware

     

    NUMBER OF

    5

    SOLE VOTING POWER 

    0 

     

    SHARES 

    BENEFICIALLY

    OWNED BY 

    6

    SHARED VOTING POWER 

    3,215,650(1)

    EACH 

    REPORTING 

    PERSON 

    7

    SOLE DISPOSITIVE POWER 

    0 

    WITH 

    8

    SHARED DISPOSITIVE POWER 

    3,215,650 (1) 

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 

    3,215,650 (1) 

    10

    CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES

    (See Instructions)

    ☐

     

    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 

    9.5%(2) 

    12

    TYPE OF REPORTING PERSON (See Instructions) 

    PN 

             
    (1)Off the Chain LP (“OTC LP”) is the record holder of 3,215,650 shares of the Issuer’s Common Stock, par value $0.0001 per share (“Common Stock”). Off the Chain Capital, LLC is the sole manager of OTC LP and may be deemed to share beneficial ownership over the Common Stock directly owned by OTC LP.

    (2)Based on 33,692,613 shares of Common Stock outstanding as of September 25, 2024 as provided by the Issuer on September 30, 2024.

     

     

     

     

    1

    NAME OF REPORTING PERSON 

    Off the Chain Capital, LLC

     

    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (See Instructions)

    (a) ☐

    (b) ☒ 

    3

    SEC USE ONLY

     

    4

    CITIZENSHIP OR PLACE OF ORGANIZATION 

    Delaware

     

    NUMBER OF

    5

    SOLE VOTING POWER 

    0 

     

    SHARES 

    BENEFICIALLY

    OWNED BY 

    6

    SHARED VOTING POWER 

    3,215,650(3)

    EACH 

    REPORTING 

    PERSON 

    7

    SOLE DISPOSITIVE POWER 

    0 

     

    WITH 

    8

    SHARED DISPOSITIVE POWER 

    3,215,650 (3) 

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 

    3,215,650 (3) 

    10

    CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES

    (See Instructions)

    ☐ 

     

    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 

    9.5%(4) 

    12

    TYPE OF REPORTING PERSON (See Instructions) 

    IA; HC 

             

    (3)OTC LP is the record holder of 3,215,650 shares of the Issuer’s Common Stock. Off the Chain Capital, LLC is the sole manager of OTC LP and may be deemed to share beneficial ownership over the Common Stock directly owned by OTC LP.

    (4)Based on 33,692,613 shares of Common Stock outstanding as of September 25, 2024 as provided by the Issuer on September 30, 2024.

     

     

     

     

    Item 1.

     

    (a)Name of Issuer.

     

    OneMedNet Corporation

     

    (b)Address of Issuer’s Principal Executive Offices.

     

    6385 Old Shady Oak Road, Suite 250 

    Eden Prairie, MN 55344.

     

    Item 2.

     

    (a) Name of Person Filing.

     

    (i)Off the Chain LP

     

    (ii)Off the Chain Capital, LLC

     

    (b) Address of Principal Business Office or, if none, Residence.

     

    (i)10337 Los Feliz Dr.,

    Orlando, FL 32836

     

    (c) Citizenship.

     

    (i)Off the Chain LP – Delaware

     

    (ii)Off the Chain Capital, LLC – Delaware

     

    (d) Title of Class of Securities.

     

    Common Stock, par value $0.0001 per share

     

    (e) CUSIP Number.

     

    68270C103

     

    Item 3.

     

    If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

     

    ☐ Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);

     

    ☐ Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);

     

    ☐ Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);

     

    ☐ Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8);

     

    ☒ An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);

     

    ☐ An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);

     

    ☐ A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);

     

    ☐ A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

     

    ☐ A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

     

    ☐ A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J);

     

     

     

     

    ☐ Group, in accordance with § 240.13d-1(b)(1)(ii)(K).

     

    Item 4.Ownership.

     

    (a) Amount Beneficially Owned.

     

    3,215,650

     

    (b) Percent of Class.

     

    9.5%

     

    (c) Number of shares as to which such person has:

     

    (i)sole power to vote or to direct the vote:

     

    Off the Chain LP: 0 

    Off the Chain Capital, LLC: 0

     

    (ii)shared power to vote or to direct the vote:

     

    Off the Chain LP: 3,215,650 

    Off the Chain Capital, LLC: 3,215,650

     

    (iii)sole power to dispose or to direct the disposition of:

     

    Off the Chain LP: 0 

    Off the Chain Capital, LLC: 0

     

    (iv)shared power to dispose or to direct the disposition of:

     

    Off the Chain LP: 3,215,650 

    Off the Chain Capital, LLC: 3,215,650

     

    Item 5.Ownership of Five Percent or Less of a Class.

     

    Not applicable.

     

    Item 6.Ownership of More than Five Percent on Behalf of Another Person.

     

    Not applicable.

     

    Item 7.    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person.

     

    Not applicable.

     

    Item 8.Identification and Classification of Members of the Group.

     

    Not applicable.

     

    Item 9.Notice of Dissolution of Group.

     

    Not applicable.

     

    Item 10.Certification.

     

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

     

     

     

     

    Item 11. Material to be Filed as Exhibits.

     

    Exhibit 99.1 Joint Filing Agreement.

     

     

     

     

    SIGNATURES

     

    After reasonable inquiry and to the best of my knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct.

     

    Dated: October 1, 2024

     

      OFF THE CHAIN LP
       
      BY: OFF THE CHAIN CAPITAL, LLC, its MANAGER
         
    By: /s/ Tom Siegel
       

    Name: Tom Siegel

    Title: Chief Financial Officer of Off the Chain Capital, LLC

         
      OFF THE CHAIN CAPITAL, LLC
         
      By:

    /s/ Tom Siegel

       

    Name: Tom Siegel

    Title: Chief Financial Officer of Off the Chain Capital, LLC

         

     

    Get the next $ONMD alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ONMD

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $ONMD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    OneMedNet Selects Palantir to Advance Healthcare AI and Data Analytics

    DENVER and MINNEAPOLIS, Oct. 06, 2025 (GLOBE NEWSWIRE) -- OneMedNet Corporation (NASDAQ:ONMD) has selected Palantir Technologies (NASDAQ:PLTR) to transform the healthcare AI and Real-World Data (RWD) analytics marketplace. Palantir's Artificial Intelligence Platform will provide the infrastructure for OneMedNet's iRWD™ near real-time AI powered provider network (‘network') enabling OneMedNet to empower life sciences, medical device, and research organizations with anonymized, regulatory-grade clinical data and advanced analytics to accelerate the development of cutting-edge medical solutions efficiently. Access to healthcare data remains a key barrier to unlocking the $868 billion market

    10/6/25 7:00:00 AM ET
    $ONMD
    $PLTR
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care
    Computer Software: Prepackaged Software
    Technology

    OneMedNet Selects Palantir to Advance Healthcare AI and Data Analytics

    OneMedNet Corporation (NASDAQ:ONMD) has selected Palantir Technologies (NASDAQ:PLTR) to transform the healthcare AI and Real-World Data (RWD) analytics marketplace. Palantir's Artificial Intelligence Platform will provide the infrastructure for OneMedNet's iRWD™ near real-time AI powered provider network ("network") enabling OneMedNet to empower life sciences, medical device, and research organizations with anonymized, regulatory-grade clinical data and advanced analytics to accelerate the development of cutting-edge medical solutions efficiently. Access to healthcare data remains a key barrier to unlocking the $868 billion market opportunity in AI-driven healthcare by 20301. OneMedNet is

    10/6/25 6:59:00 AM ET
    $ONMD
    $PLTR
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care
    Computer Software: Prepackaged Software
    Technology

    OneMedNet Expands Into $1.5B Healthcare Data Annotation Market With MedCase

    MINNEAPOLIS, Sept. 24, 2025 (GLOBE NEWSWIRE) -- OneMedNet Corporation (NASDAQ:ONMD) ("OneMedNet," the "Company," "we," "us" or "our"), a leader in AI-powered Real-World Data (RWD), announced a strategic partnership with Medcase, a worldwide network of healthcare professionals focused on medical data annotation. This collaboration establishes a new market entry point for OneMedNet and opens a high-growth revenue channel in the healthcare AI ecosystem. Strategic Expansion into Healthcare Data Annotation The global healthcare data annotation market, valued at $1.5 billion in 2025 and projected to be $2.8 billion by 2030, has entered a pivotal growth phase1. Scale AI's $14.8B investment from

    9/24/25 8:45:00 AM ET
    $ONMD
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    $ONMD
    SEC Filings

    View All

    OneMedNet Corp filed SEC Form 8-K: Other Events

    8-K - OneMedNet Corp (0001849380) (Filer)

    9/15/25 8:30:39 AM ET
    $ONMD
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    SEC Form 424B3 filed by OneMedNet Corp

    424B3 - OneMedNet Corp (0001849380) (Filer)

    8/13/25 5:24:56 PM ET
    $ONMD
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    SEC Form 10-Q filed by OneMedNet Corp

    10-Q - OneMedNet Corp (0001849380) (Filer)

    8/13/25 4:57:25 PM ET
    $ONMD
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    $ONMD
    Financials

    Live finance-specific insights

    View All

    OneMedNet Reports 80% Reduction in Debt Enabling Focus On Growth

    MINNEAPOLIS, Aug. 14, 2025 (GLOBE NEWSWIRE) -- OneMedNet Corporation (NASDAQ:ONMD) ("OneMedNet," the "Company," "we," "us" or "our"), a leader in AI-powered Real-World Data (RWD), announced its financial results for the second quarter ended June 30, 2025, including its significantly improved balance sheet. Second Quarter and First Half 2025 Financial Highlights Improved Balance Sheet: Due to the combination of debt conversions, vendor repayments, and highly discounted debt settlements, total liabilities have been reduced from $19.7 million as of December 31, 2024, to $6.2 million as of June 30, 2025, a reduction of approximately $13.5 million. Additional discounted debt settl

    8/14/25 7:45:00 AM ET
    $ONMD
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    $ONMD
    Leadership Updates

    Live Leadership Updates

    View All

    Dr. Kenneth Alleyne Joins OneMedNet Board of Directors

    MINNEAPOLIS, March 03, 2025 (GLOBE NEWSWIRE) -- OneMedNet Corporation (NASDAQ:ONMD) ("OneMedNet"), the leading Real World Data platform powered by AI-driven de-identification, announces the appointment of Dr. Kenneth Alleyne to its Board of Directors. A board-certified orthopedic surgeon specializing in sports medicine, Dr. Alleyne will assume the role of Chair of the Audit Committee, bringing extensive expertise in healthcare, insurance, investment, and corporate governance to the organization. Dr. Alleyne is the managing partner of HartHaven Partners, a healthcare consulting firm supporting private equity and venture capital firms. He co-founded NextLevel Health Partners and Zing Health

    3/3/25 8:35:00 AM ET
    $ONMD
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    OneMedNet Announces Exciting New Collaboration with Bayer's AI Innovation Platform to Help Accelerate Healthcare AI Development

    MINNEAPOLIS, Dec. 02, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (NASDAQ:ONMD) ("OneMedNet" or the "Company"), a Real-World Data (RWD) platform — has announced its collaboration with Bayer's AI Innovation Platform (AIIP). By joining AIIP, the partnership aims to empower the developer teams of healthcare organizations and startups in building scalable and compliant AI-powered medical imaging software products. "We are thrilled to join forces with Bayer's AI Innovation Platform," said Aaron Green, CEO & President of OneMedNet. "This collaboration allows us to combine our regulatory-grade real-world data platform, which aggregates data from our provider network of over 1,400 healthcare

    12/2/24 8:30:00 AM ET
    $ONMD
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    OneMedNet appoints new CFO

    MINNEAPOLIS, Sept. 10, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (NASDAQ:ONMD) ("OneMedNet" or the "Company"), the leading curator of regulatory-grade Real World Data (RWD), has announced that Bob Golden has joined the OneMedNet Executive Team as Chief Financial Officer spearheading all aspects of the company's financial and accounting operations while continuing to serve as a member of the Board of Directors. Mr. Golden is a Certified Public Accountant with more than 40 years of experience. Mr. Golden has served as the Managing Partner of Cohen, Bender & Golden LLP since 2015, where he provides consulting, accounting and tax services to middle market businesses and owners. Mr. Golde

    9/10/24 8:45:00 AM ET
    $ONMD
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    $ONMD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by OneMedNet Corp

    SC 13G - OneMedNet Corp (0001849380) (Subject)

    11/12/24 3:35:37 PM ET
    $ONMD
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    SEC Form SC 13G filed by OneMedNet Corp

    SC 13G - OneMedNet Corp (0001849380) (Subject)

    10/1/24 5:01:18 PM ET
    $ONMD
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    SEC Form SC 13G filed by OneMedNet Corp

    SC 13G - OneMedNet Corp (0001849380) (Subject)

    8/5/24 5:15:39 PM ET
    $ONMD
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care